[Clinical considerations on the therapeutic action of a new drug with anti-angina action (FPDFPA)].
D002317:Cardiovascular Agents; D003327:Coronary Disease; D006801:Humans; D011299:Prenylamine
D002317:Cardiovascular Agents; D011299:Prenylamine
CORONARY DISEASE; SEGONTIN